| Dr Susan Harrington Miller, OD | |
|
204 W Chestnut St, Butler, MO 64730-1554 | |
| (660) 679-3261 | |
| (660) 679-6213 |
| Full Name | Dr Susan Harrington Miller |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 30 Years |
| Location | 204 W Chestnut St, Butler, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518933043 | NPI | - | NPPES |
| 318165117 | Medicaid | MO | |
| 22386037 | Other | MO | BLUECROSSBLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | T03247 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Noe, Miller And Miller, Llc | 8729153473 | 2 |
News Archive
A new paper published in The Lancet Child & Adolescent Health co-authored by a University of Warwick researcher provides standardized scores for The Parent Report of Children's Abilities Revised questionnaire.
The Obama administration's announcement last week that consumers whose policies had been canceled could buy catastrophic health plans and were also exempt from the law's mandate in the first year spurred handwringing in some quarters.
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Obese patients undergoing colon surgery are 60 percent more likely to develop dangerous and costly surgical-site infections than their normal-weight counterparts, new Johns Hopkins research suggests.
› Verified 5 days ago
| Provider Name | Noe, Miller & Miller, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417974411 PECOS PAC ID: 8729153473 Enrollment ID: O20080815000136 |
News Archive
A new paper published in The Lancet Child & Adolescent Health co-authored by a University of Warwick researcher provides standardized scores for The Parent Report of Children's Abilities Revised questionnaire.
The Obama administration's announcement last week that consumers whose policies had been canceled could buy catastrophic health plans and were also exempt from the law's mandate in the first year spurred handwringing in some quarters.
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Obese patients undergoing colon surgery are 60 percent more likely to develop dangerous and costly surgical-site infections than their normal-weight counterparts, new Johns Hopkins research suggests.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Harrington Miller, OD 204 W Chestnut St, Po Box 47, Butler, MO 64730-1554 Ph: (660) 679-3261 | Dr Susan Harrington Miller, OD 204 W Chestnut St, Butler, MO 64730-1554 Ph: (660) 679-3261 |
News Archive
A new paper published in The Lancet Child & Adolescent Health co-authored by a University of Warwick researcher provides standardized scores for The Parent Report of Children's Abilities Revised questionnaire.
The Obama administration's announcement last week that consumers whose policies had been canceled could buy catastrophic health plans and were also exempt from the law's mandate in the first year spurred handwringing in some quarters.
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Obese patients undergoing colon surgery are 60 percent more likely to develop dangerous and costly surgical-site infections than their normal-weight counterparts, new Johns Hopkins research suggests.
› Verified 5 days ago
Noe, Miller & Miller, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 204 W Chestnut St, Butler, MO 64730 Phone: 660-679-3261 | |
Dr. David Miller, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1100 E Nursery St, Butler, MO 64730 Phone: 660-679-3261 Fax: 660-679-6213 |